Pharmacy Benefit Managers (PBMs) are often discussed in terms of cost but their value extends far beyond savings
Among these, glucagon-like peptide-1 receptor agonists (GLP1RAs) have attracted particular attention for their profound effects on body weight, glycemic control, and cardiovascular outcomes [4,5] , which extend beyond metabolic effects [4] , alongside emerging evidence of liver-specific benefits [5,6]
Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naive patients: analysis of pooled vildagliptin monotherapy database
Recommended Doses and Injection Schedule Clinical trials have used once-weekly subcutaneous doses ranging from approximately 1 mg to 12 mg, escalated gradually under medical supervision
If it has been longer than 5 days, do not take the missed dose